GHRP-2
Growth Hormone- Molecular Formula
- C45H55N9O6
- Molar Mass
- 818.0 g/mol
- CAS Number
- 158861-67-7
- Purity Standard
- 99%+ (HPLC Verified)
- Amino Acid Sequence
- D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
Overview
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide growth hormone secretagogue with one of the highest GH-releasing potencies in its class. The incorporation of D-2-naphthylalanine in place of D-tryptophan (as in GHRP-6) provides enhanced receptor binding and a somewhat improved selectivity profile.
Research demonstrates GHRP-2 produces substantial GH release while causing less appetite stimulation than GHRP-6, though still more than highly selective compounds like ipamorelin. It does stimulate modest cortisol, prolactin, and ACTH release, indicating activation of multiple hypothalamic-pituitary pathways.
The compound's high potency makes it valuable for research requiring maximal GH stimulation, such as pituitary reserve testing or studies of GH-deficient states. Its robust GH response in aged subjects has made it a useful tool in somatopause research.
GHRP-2 represents an important step in the evolution of GH secretagogues, bridging the gap between first-generation compounds like GHRP-6 and the highly selective agents developed subsequently. Its intermediate selectivity profile provides researchers with options for balancing GH potency against hormonal side effects.
Synthesis Overview
GHRP-2 is synthesized via Fmoc solid-phase peptide synthesis incorporating D-alanine, D-2-naphthylalanine (D-2-Nal), and D-phenylalanine as non-natural amino acids. The D-2-Nal residue requires specialized coupling protocols due to steric considerations. Following synthesis and cleavage, purification is achieved via preparative HPLC with careful separation from D/L epimer impurities. Final characterization includes mass spectrometry, HPLC purity, and chiral analysis.
Research Applications
- High-potency GH secretagogue receptor activation studies
- Comparative GH release analysis with GHRP-6 and ipamorelin
- ACTH and cortisol co-stimulation research
- Pituitary reserve and GH secretory capacity assessment
- Aging-related GH decline intervention studies
- GHS-R1a receptor binding and signal transduction analysis
Related Compounds
C152H252N44O42
3,367.97 g/mol
CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) that has been structurally modified to extend its biological half-life throu...
View Full ProfileC38H49N9O5
711.85 g/mol
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that activates the ghrelin/growth hormone secretagogue receptor (GHS-R1a) with rema...
View Full ProfileC27H36N4O5S
528.67 g/mol
MK-677 (Ibutamoren) is an orally bioavailable, non-peptide growth hormone secretagogue that mimics the action of ghrelin at the GHS-R1a receptor. Whil...
View Full Profile